{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:42Z","timestamp":1786982202171,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12031-020-01745-y","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T10:04:38Z","timestamp":1605175478000},"page":"1197-1204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Differential Expression of Cytokine-Coding Genes among Migraine Patients with and without Aura and Normal Subjects"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-0591","authenticated-orcid":false,"given":"Mohammad","family":"Taheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fwad","family":"Nicknafs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Hesami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolreza","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Arsang-Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"1745_CR1","unstructured":"(2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743\u2013800"},{"key":"1745_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.652","volume":"42","author":"V Anttila","year":"2010","unstructured":"Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM, Calafato MS, Nyholt DR, Dimas AS, Freilinger T, M\u00fcller-Myhsok B (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22. 1. Nat Genet 42:869","journal-title":"Nat Genet"},{"key":"1745_CR3","first-page":"245","volume":"11","author":"P Bruno","year":"2007","unstructured":"Bruno P, Carpino F, Carpino G, Zicari A (2007a) An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 11:245","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1745_CR4","first-page":"245","volume":"11","author":"PP Bruno","year":"2007","unstructured":"Bruno PP, Carpino F, Carpino G, Zicari A (2007b) An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 11:245\u2013248","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1745_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ng.856","volume":"43","author":"DI Chasman","year":"2011","unstructured":"Chasman DI, Sch\u00fcrks M, Anttila V, de Vries B, Schminke U, Launer LJ, Terwindt GM, van den Maagdenberg AM, Fendrich K, V\u00f6lzke H (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43:695\u2013698","journal-title":"Nat Genet"},{"key":"1745_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2018.12.004","volume":"844","author":"P Conti","year":"2019","unstructured":"Conti P, D'ovidio C, Conti C, Gallenga CE, Lauritano D, Caraffa A, Kritas SK, Ronconi G (2019) Progression in migraine: role of mast cells and pro-inflammatory and anti-inflammatory cytokines. Eur J Pharmacol 844:87\u201394","journal-title":"Eur J Pharmacol"},{"key":"1745_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10072-014-1931-1","volume":"36","author":"H Duarte","year":"2015","unstructured":"Duarte H, Teixeira AL, Rocha NP, Domingues RB (2015) Increased interictal serum levels of CXCL8\/IL-8 and CCL3\/MIP-1\u03b1 in migraine. Neurol Sci 36:203\u2013208","journal-title":"Neurol Sci"},{"key":"1745_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jneuroim.2005.10.005","volume":"171","author":"I Fidan","year":"2006","unstructured":"Fidan I, Y\u00fcksel S, \u00ddmir T, Irke\u00e7 C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171:184\u2013188","journal-title":"J Neuroimmunol"},{"key":"1745_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ng.2307","volume":"44","author":"T Freilinger","year":"2012","unstructured":"Freilinger T, Anttila V, de Vries B, Malik R, Kallela M, Terwindt GM, Pozo-Rosich P, Winsvold B, Nyholt DR, van Oosterhout WP (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44:777\u2013782","journal-title":"Nat Genet"},{"key":"1745_CR10","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1073\/pnas.86.10.3803","volume":"86","author":"PH Hart","year":"1989","unstructured":"Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci 86:3803\u20133807","journal-title":"Proc Natl Acad Sci"},{"key":"1745_CR11","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.4049\/jimmunol.168.5.2456","volume":"168","author":"J Major","year":"2002","unstructured":"Major J, Fletcher JE, Hamilton TA (2002) IL-4 pretreatment selectively enhances cytokine and chemokine production in lipopolysaccharide-stimulated mouse peritoneal macrophages. J Immunol 168:2456\u20132463","journal-title":"J Immunol"},{"key":"1745_CR12","doi-asserted-by":"publisher","first-page":"s18","DOI":"10.1007\/s101940300003","volume":"4","author":"GC Manzoni","year":"2003","unstructured":"Manzoni GC, Torelli P (2003) Epidemiology of migraine. J Headache Pain 4:s18\u2013s22","journal-title":"J Headache Pain"},{"key":"1745_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s001090050130","volume":"75","author":"P Martelletti","year":"1997","unstructured":"Martelletti P, Stirparo G, Morrone S, Rinaldi C, Giacovazzo M (1997) Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients. J Mol Med (Berl) 75:448\u2013453","journal-title":"J Mol Med (Berl)"},{"key":"1745_CR14","first-page":"393","volume":"21","author":"P Martelletti","year":"2001","unstructured":"Martelletti P, Zicari A, Realacci M, Stirparo G, de Filippis S, Fiore G, Solimeo M, Rinaldi C, Morrone S, Giacovazzo M (2001) Up-regulation of inducible nitric oxide synthase (NOS-2) and cyclo-oxygenase type 2 (COX-2) switches to TH2-type response in migraine. Cephalalgia 21:393\u2013394","journal-title":"Cephalalgia"},{"key":"1745_CR15","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1182\/blood-2009-11-255174","volume":"116","author":"JD Milner","year":"2010","unstructured":"Milner JD, Orekov T, Ward JM, Cheng L, Torres-Velez F, Junttila I, Sun G, Buller M, Morris SC, Finkelman FD, Paul WE (2010) Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood 116:2476\u20132483","journal-title":"Blood"},{"key":"1745_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S1474-4422(18)30085-1","volume":"17","author":"J Olesen","year":"2018","unstructured":"Olesen J (2018) International classification of headache disorders. Lancet Neurol 17:396\u2013397","journal-title":"Lancet Neurol"},{"key":"1745_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jneuroim.2017.09.008","volume":"313","author":"AB Oliveira","year":"2017","unstructured":"Oliveira AB, Bachi ALL, Ribeiro RT, Mello MT, Tufik S, Peres MFP (2017) Unbalanced plasma TNF-\u03b1 and IL-12\/IL-10 profile in women with migraine is associated with psychological and physiological outcomes. J Neuroimmunol 313:138\u2013144","journal-title":"J Neuroimmunol"},{"key":"1745_CR18","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1526-4610.2005.05135.x","volume":"45","author":"F Perini","year":"2005","unstructured":"Perini F, D'andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V (2005) Plasma cytokine levels in migraineurs and controls. Headache: J Head Face Pain 45:926\u2013931","journal-title":"Headache: J Head Face Pain"},{"key":"1745_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1526-4610.2006.00337.x","volume":"46","author":"P Sarchielli","year":"2006","unstructured":"Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache: J Head Face Pain 46:200\u2013207","journal-title":"Headache: J Head Face Pain"},{"key":"1745_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0306-9877(92)90181-B","volume":"39","author":"R Smith","year":"1992","unstructured":"Smith R (1992) The cytokine theory of headache. Med Hypotheses 39:168\u2013174","journal-title":"Med Hypotheses"},{"key":"1745_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1468-2982.2000.00025.x","volume":"20","author":"G Stirparo","year":"2000","unstructured":"Stirparo G, Zicari A, Favilla M, Lipari M, Martelletti P (2000) Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia 20:100\u2013106","journal-title":"Cephalalgia"},{"key":"1745_CR22","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1212\/WNL.64.10_suppl_2.S9","volume":"64","author":"C Waeber","year":"2005","unstructured":"Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64:S9\u2013S15","journal-title":"Neurology"},{"key":"1745_CR23","doi-asserted-by":"publisher","first-page":"e00950","DOI":"10.1002\/brb3.950","volume":"8","author":"WZ Yeh","year":"2018","unstructured":"Yeh WZ, Blizzard L, Taylor BV (2018) What is the actual prevalence of migraine? Brain Behav 8:e00950\u2013e00950","journal-title":"Brain Behav"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01745-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T10:56:58Z","timestamp":1620039418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01745-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01745-y","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"4 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Shahid Beheshti University of Medical Sciences (IR.SBMU.RETECH.REC.1398.588). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have nothing to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}